Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barni

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
British Journal of Haematology|April 12, 2001
Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of diseaseC Gambacorti-Passerini, R Barni, E Marchesi, et al.
Blood|February 26, 2000
Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplificationP le Coutre, E Tassi, M Varella-Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patientsC Bertazzoli, E Marchesi, L Passoni, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
British Journal of Haematology|April 12, 2001
Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of diseaseC Gambacorti-Passerini, R Barni, E Marchesi, et al.
Blood|February 26, 2000
Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplificationP le Coutre, E Tassi, M Varella-Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patientsC Bertazzoli, E Marchesi, L Passoni, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Pageof 2